GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GC Cell Corp (XKRX:144510) » Definitions » Debt-to-Equity

GC Cell (XKRX:144510) Debt-to-Equity : 0.19 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is GC Cell Debt-to-Equity?

GC Cell's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩60,300 Mil. GC Cell's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩39,942 Mil. GC Cell's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩523,667 Mil. GC Cell's debt to equity for the quarter that ended in Mar. 2024 was 0.19.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for GC Cell's Debt-to-Equity or its related term are showing as below:

XKRX:144510' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.13   Med: 0.15   Max: 0.19
Current: 0.19

During the past 11 years, the highest Debt-to-Equity Ratio of GC Cell was 0.19. The lowest was 0.13. And the median was 0.15.

XKRX:144510's Debt-to-Equity is ranked better than
54.92% of 193 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.23 vs XKRX:144510: 0.19

GC Cell Debt-to-Equity Historical Data

The historical data trend for GC Cell's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GC Cell Debt-to-Equity Chart

GC Cell Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.15 0.14 0.14 0.17

GC Cell Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.15 0.15 0.17 0.19

Competitive Comparison of GC Cell's Debt-to-Equity

For the Diagnostics & Research subindustry, GC Cell's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GC Cell's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, GC Cell's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where GC Cell's Debt-to-Equity falls into.



GC Cell Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

GC Cell's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

GC Cell's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GC Cell  (XKRX:144510) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


GC Cell Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of GC Cell's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


GC Cell (XKRX:144510) Business Description

Traded in Other Exchanges
N/A
Address
30 beongil to giheung-gu, Gyeonggi, 107 Lee Hyun, Yongin, KOR, 16 924
GC Cell Corp engages in the provision of anti-cancer immunotherapy. The company is developing an anticancer drug, which is in Phase II clinical trials; and stem cell treatment drugs. It also provides cell banking, sample inspection, clinical trial, and bio logistics services.

GC Cell (XKRX:144510) Headlines

No Headlines